{
    "nct_id": "NCT06855628",
    "official_title": "Assessment Of A Novel Metabolic Imaging Modalities As A Predictor Of Therapeutic Efficacy In Glioblastoma (GBM)",
    "inclusion_criteria": "* Any participant that consents to entry into the Phase II BPM31510 parent study (BPM31510IV-11)\n* Women of childbearing potential must have a negative pregnancy test\n* Ability to understand and the willingness to provide written informed consent.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Refuse to have an IV\n* Allergy to MRI contrasts\n* Diabetic patients who are taking insulin",
    "miscellaneous_criteria": ""
}